Stock News - Alto Neuroscience, Inc. $ANRO
Latest Stock News for $ANRO
Alto Neuroscience Reports Phase 2 Study Results for ALTO-101, No Statistical Significance Achieved
Expected Stock impact: Slightly Negative
2026-04-01 20:56:24
Alto Neuroscience Secures $120 Million in Private Placement Financing to Advance ALTO-207 Development
Expected Stock impact: Very Positive
2026-03-16 11:09:14
Alto Neuroscience Reports Strong 2025 Financial Results and Advances Key Clinical Trials
Expected Stock impact: Noticeably Positive
2026-03-16 10:08:21
